Ronald Peck
Net worth: 439 935 $ as of 2024-04-29
Profile
Ronald Peck holds the position of Chief Medical Officer of Arvinas, Inc. In the past Dr. Peck occupied the position of Vice President-Yervoy Global Development Lead at Bristol Myers Squibb Co., Chief Medical Officer for Kolltan Pharmaceuticals, Inc., Senior Vice President-Clinical Research at Tesaro, Inc. and Assistant Professor at the University of Virginia. Dr. Peck received an undergraduate degree from Georgetown University and a doctorate from Sidney Kimmel Medical College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARVINAS, INC.
0.02% | 2024-03-30 | 13,922 ( 0.02% ) | 439 935 $ | 2024-04-29 |
Former positions of Ronald Peck
| Companies | Position | End |
|---|---|---|
| ARVINAS, INC. | Chief Tech/Sci/R&D Officer | 2024-03-17 |
| TESARO INC | Chief Tech/Sci/R&D Officer | 2019-06-30 |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Chief Tech/Sci/R&D Officer | 2016-11-30 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2015-04-30 |
| University of Virginia | Corporate Officer/Principal | 2000-01-31 |
Training of Ronald Peck
| Georgetown University | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ARVINAS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
- Stock Market
- Insiders
- Ronald Peck